Who
Peter J. Kuipers
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Clover Health Investments; Director, Invacare Holdings; EVP, Executive Advisor, Omnicell.
In numbers
- Trades disclosed
- 169
- Buys
- 0
- Sells
- 24
- Bought
- $0
- Sold
- $17.1M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 1 Sep 2015
- Last trade
- 29 Jan 2026
- Last filed
- 2 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jan 2026filed 2 Feb 2026 | CLOV Clover Health InvestmentsManaged Care & Insurers | SEC FORM 4 Code F | $362K156,856 at $2.31 | filing |
| 29 Jan 2026filed 2 Feb 2026 | CLOV Clover Health InvestmentsManaged Care & Insurers | SEC FORM 4 Code F | $362K156,856 at $2.31 | filing |
| 29 Oct 2025filed 31 Oct 2025 | CLOV Clover Health InvestmentsManaged Care & Insurers | SEC FORM 4 Code F | $791K217,382 at $3.64 | filing |
| 29 Jul 2025filed 31 Jul 2025 | CLOV Clover Health InvestmentsManaged Care & Insurers | SEC FORM 4 Code F | $628K217,382 at $2.89 | filing |
| 19 May 2025filed 21 May 2025 | CLOV Clover Health InvestmentsManaged Care & Insurers | SEC FORM 4 Code A | —326,647 at $0.00 | filing |
| 29 Apr 2025filed 1 May 2025 | CLOV Clover Health InvestmentsManaged Care & Insurers | SEC FORM 4 Code F | $2.8M825,989 at $3.45 | filing |
| 1 Nov 2023filed 3 Nov 2023 | Invacare Holdings | SEC FORM 4 Code A | —66,860 at $0.00 | filing |
| 15 Jun 2023filed 16 Jun 2023 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $166K2,292 at $72.32 | filing |
| 15 Dec 2022filed 19 Dec 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $203K4,196 at $48.44 | filing |
| 26 Aug 2022filed 30 Aug 2022 | OMCL Omnicelloption or derivative · Medical Devices | SEC FORM 4 Code M | —4,040 at $0.00 | filing |
| 26 Aug 2022filed 30 Aug 2022 | OMCL Omnicelloption or derivative · Medical Devices | SEC FORM 4 Code M | —11,460 at $0.00 | filing |
| 26 Aug 2022filed 30 Aug 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Code M | $179K4,040 at $44.25 | filing |
| 26 Aug 2022filed 30 Aug 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Code M | $904K11,460 at $78.91 | filing |
| 26 Aug 2022filed 30 Aug 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Sold | $2,06619 at $108.74 | filing |
| 26 Aug 2022filed 30 Aug 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Sold | $1.7M15,481 at $108.29 | filing |
| 22 Aug 2022filed 24 Aug 2022 | OMCL Omnicelloption or derivative · Medical Devices | SEC FORM 4 Code M | —11,000 at $0.00 | filing |
| 22 Aug 2022filed 24 Aug 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Code M | $487K11,000 at $44.25 | filing |
| 22 Aug 2022filed 24 Aug 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Sold | $1.2M11,000 at $105.93 | filing |
| 15 Jun 2022filed 17 Jun 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $474K4,193 at $113.11 | filing |
| 14 Mar 2022filed 16 Mar 2022 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —19,040 at $0.00 | filing |
News
Reviewing Omnicell (NASDAQ:OMCL) & Baxter International (NYSE:BAX)OMCL · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Peter J. Kuipers; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.